ARTG Entry

TIBSOVO

ARTG entry for TIBSOVO (ivosidenib), ARTG 391874 — Product Information, dosage form, registration history. Compiled by arcimedes.

• Sponsor: Servier Laboratories (Aust)
• Active ingredient: ivosidenib
• Therapeutic area: Oncology

TGA Public Summary — ARTG 391874